Full Text View
Tabular View
Study Results
Related Studies
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-Abdominal Infection
This study has been completed.
Study NCT00195351   Information provided by Wyeth
First Received: September 12, 2005   Last Updated: April 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Appendicitis
Cholecystitis
Cross Infection
Diverticulitis
Peritonitis
Additional conditions recognized in this trial
Acalculous Cholecystitis
Communicable Diseases
Infection
More general conditions related to this trial
Biliary Tract Diseases
Cecal Diseases
Digestive System Diseases
Gallbladder Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Pathologic Processes
Peritoneal Diseases
Interventions listed in this trial
tigecycline
ceftriaxone sodium + metronidazole
Additional drug interventions recognized in this trial
Ceftriaxone
Metronidazole
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Wyeth


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services